|
AMAG Pharmaceuticals' magnetic technology doesn't make things stick, it makes things stick out. The company, formerly called Advanced Magnetics, uses its expertise in iron oxide nanoparticles to create organ-specific diagnostic contrast agents used in magnetic resonance imaging (MRI) tests. It has two products on the market: Feridex I.V. (for the diagnosis of liver lesions) and GastroMARK (used for delineating the bowel in abdominal imaging). The firm is developing Combidex as a contrast agent for the diagnosis of metastatic lymph nodes. Another product, Feraheme (ferumoxytol), received FDA approval as an iron replacement therapy for anemic patients in 2009.
|
| | | Contact Information | |
Address: |
100 Hayden Ave
Lexington, MA 02421
| | Phone: | 617-498-3300 | | Fax: | 617-499-3361 |
|
| Financial
Highlights | | Fiscal Year End: | September | | Revenue (2008): | 1.90 M | | Revenue Growth (1 yr): | (-24.10%) | | Employees (2008): | 259 | | Employee Growth (1 yr): | 194.30% |
|
|
Key People
| | • |
Chairman:
Michael A. Narachi
| | • |
President, CEO, and Director:
Brian J.G. Pereira
| | • |
EVP, CFO, and Chief Business Officer:
David A. Arkowitz
|
|
|
